<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>6
<FILENAME>a2106609zex-10_13.htm
<DESCRIPTION>EXHIBIT 10.13
<TEXT>
<HTML>
<HEAD>

</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>

<div>

<p align="center" style="color:black;font-variant:small-caps;font-weight:bold;margin:0in 0in .0001pt;page-break-after:avoid;text-align:center;"><b><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;font-variant:normal;text-transform:uppercase;">CONFIDENTIAL TREATMENT REQUESTED</font></b></p>

<p style="color:black;font-variant:small-caps;font-weight:bold;margin:0in 0in .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;font-variant:normal;text-transform:uppercase;">&nbsp;</font></b></p>

<p style="color:black;font-variant:small-caps;font-weight:bold;margin:0in 0in .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;font-variant:normal;text-transform:uppercase;">Exhibit 10.13</font></b></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">WAIVER AND TERMINATION AGREEMENT DATED 8 NOVEMBER, 2002 (THE
&#147;EFFECTIVE DATE&#148;)</font></u></b></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RECITALS:</font></u></b></p>

<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>

<p style="font-family:'Times New Roman';margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;text-transform:uppercase;">Whereas</font><font size="2" style="font-size:10.0pt;">, Elan
Corporation, plc, an Irish public limited company (&#147;<b><i><font style="font-style:italic;font-weight:bold;">Elan</font></i></b>&#148;), DepoMed, Inc., a California
corporation (the &#147;<b><i><font style="font-style:italic;font-weight:bold;">Company</font></i></b>&#148;),
Elan Pharma International Limited, a private limited company incorporated under
the laws of Ireland (&#147;<b><font style="font-weight:bold;">EPIL</font></b>&#148;), and DepoMed Development Ltd., a
Bermuda exempted limited liability company (&#147;<b><i><font style="font-style:italic;font-weight:bold;">Newco</font></i></b>&#148;), entered into a License Agreement,
dated January 21, 2000 (the &#147;<b><i><font style="font-style:italic;font-weight:bold;">Elan License Agreement</font></i></b>&#148;), which set forth the terms and
conditions of a license from Elan to Newco of certain intellectual property of
Elan.</font></p>

<p style="margin:0in -.5in .0001pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';margin:0in 0in 12.0pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Whereas</font><font size="2" style="font-size:10.0pt;">, the Company has entered that certain
Development and License Agreement, dated as of May 28, 2002 (the &#147;<b><i><font style="font-style:italic;font-weight:bold;">BLI License Agreement</font></i></b>&#148;),
by and between the Company and Biovail Laboratories Incorporated (&#147;<b><i><font style="font-style:italic;font-weight:bold;">BLI</font></i></b>&#148;) and that
certain Stock Purchase Agreement, dated as of May 28, 2002, by and between the
Company and BLI (together with the BLI License Agreement, the &#147;<b><i><font style="font-style:italic;font-weight:bold;">BLI Agreements</font></i></b>&#148;).</font></p>

<p align="left" style="margin:0in 0in 12.0pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in 12.0pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="text-transform:uppercase;">Whereas, E</font>PIL terminated the [***] (as
defined in the Elan License Agreement) by notice in writing to [***] dated 26
August 2002 (the &#147;<b><font style="font-weight:bold;">[***]</font></b>&#148;), and notified Newco and Depomed of
this action.</font></p>

<p align="left" style="margin:0in 0in 12.0pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in 12.0pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="text-transform:uppercase;">Whereas, </font>Elan, EPIL, Newco and Depomed
desire to terminate the license to Newco of the rights under the [***] (as
defined in the Elan License Agreement) and certain additional rights granted to
Newco under the Elan License Agreement.</font></p>

<p align="left" style="margin:0in 0in 12.0pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="text-transform:uppercase;">Whereas, </font>Elan desires to waive certain
of its accrued rights under the Elan License Agreement up to the Effective Date
that may arise as a result of the transactions contemplated by the BLI
Agreements up to the Effective Date and DepoMed desires to waive certain of its
accrued rights under the Elan License Agreement up to the Effective Date that
may arise as a result of the termination of the [***].</font></p>

<p align="left" style="margin:0in 0in 12.0pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">WAIVER AND
TERMINATION:</font></u></b></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><font style="font-weight:bold;">Waiver by Elan.</font></b></font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt .5in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">Elan hereby irrevocably waives any
accrued rights Elan may have under Section 8.4 of the Elan License Agreement </font><font size="2" style="font-size:10.0pt;">up to the Effective Date </font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">to terminate the Elan
License Agreement as a result of any or all of the transactions by Depomed <font style="color:blue;letter-spacing:0pt;text-decoration:underline;"><font color="black" style="color:windowtext;text-decoration:none;">from the beginning of time </font></font></font><font size="2" style="font-size:10.0pt;">up to the Effective Date </font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">under by the BLI
Agreements, and Elan </font><font size="2" style="font-size:10.0pt;">fully
and finally</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt .5in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt .5in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt .5in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">THE SYMBOL [***] IS USED TO INDICATE THAT A
PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPERATELY WITH THE
COMMISSION.&#160; CONFIDENTIAL TREATMENT HAS
BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION.</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt .5in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">&nbsp;</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:-.15pt;">
<!-- ZEQ.=1,SEQ=1,EFW="2106609",CP="DEPOMED, INC.",DN="5",CHK=239650,FOLIO='',FILE="DISK008:[03PAL8.03PAL1238.EDGAR]EX10-13_1238.CHC",USER="DROCCON",CD='Mar 28 16:24 2003' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt .5in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">releases and discharges Depomed from</font><font style="color:blue;letter-spacing:0pt;text-decoration:underline;"><font size="2" color="black" style="color:windowtext;font-size:10.0pt;text-decoration:none;"> any and</font></font><font size="2" style="font-size:10.0pt;"> all </font><font style="color:blue;letter-spacing:0pt;text-decoration:underline;"><font size="2" color="black" style="color:windowtext;font-size:10.0pt;text-decoration:none;">manner of actions or
claims that Elan may have by reason thereof against Depomed from the beginning
of time to the Effective Date under the </font></font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">Elan License Agreement.</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">2.</font><font size="1" style="font-size:3.0pt;letter-spacing:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;letter-spacing:0pt;">Termination of the EPIL Sub-License and
Waivers.</font></b></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">With reference to Clause 1 hereof, Elan,
EPIL, Newco and Depomed hereby agree to terminate the EPIL Sub-License (as
defined in the Elan License Agreement) and the EPIL License (as defined in the
Elan License Agreement) insofar as the EPIL License licensed the EGTS Patents
and the EGTS Know-How to Newco with effect from the [***].</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">With effect from the [***], the
definition of &#147;Elan Intellectual Property&#148; in the Elan License Agreement shall
be amended by the deletion of paragraph (iii) and all references to &#147;Elan
Intellectual Property&#148; in the Elan License Agreement and the JDOA (including
without limitation in Clauses 4.1 and 4.2 of the Elan License Agreement) shall
thereafter be construed accordingly.</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">2.3</font><font size="1" style="font-size:3.0pt;letter-spacing:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">DepoMed and Newco
hereby irrevocably waive any accrued rights DepoMed or Newco may have under the
Elan License Agreement (and/or the </font><font size="2" style="font-size:10.0pt;">Subscription, Joint Development And Operating
Agreement dated January 21, 2000 (&#147;<b><font style="font-weight:bold;">JDOA</font></b>&#148;)) </font><font style="color:blue;letter-spacing:0pt;text-decoration:underline;"><font size="2" color="black" style="color:windowtext;font-size:10.0pt;text-decoration:none;">from the beginning
of time </font></font><font size="2" style="font-size:10.0pt;">up to
the Effective Date </font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">arising out of the termination by Elan, EPIL or any of its
affiliates of the [***] and Depomed and Newco </font><font size="2" style="font-size:10.0pt;">fully and finally release and discharge Elan, EPIL and
</font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">any
of its affiliates </font><font size="2" style="font-size:10.0pt;">from</font><font style="color:blue;letter-spacing:0pt;text-decoration:underline;"><font size="2" color="black" style="color:windowtext;font-size:10.0pt;text-decoration:none;"> any and</font></font><font size="2" style="font-size:10.0pt;"> all </font><font style="color:blue;letter-spacing:0pt;text-decoration:underline;"><font size="2" color="black" style="color:windowtext;font-size:10.0pt;text-decoration:none;">manner of actions or
claims that </font></font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">Depomed or Newco <font style="color:blue;letter-spacing:0pt;text-decoration:underline;"><font color="black" style="color:windowtext;text-decoration:none;">may have by reason thereof against </font></font></font><font size="2" style="font-size:10.0pt;">Elan, EPIL and </font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">any of its affiliates<font style="color:blue;letter-spacing:0pt;text-decoration:underline;"><font color="black" style="color:windowtext;text-decoration:none;"> from the beginning of time to the
Effective Date under the </font></font>Elan License Agreement and/or the
JDOA.</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt .5in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">.</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">3</font><font size="1" style="font-size:3.0pt;letter-spacing:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;letter-spacing:0pt;">Waivers and Releases.</font></b></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt .5in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The parties hereto acknowledge and agree that the
waivers and releases contained herein are specific in nature, do not constitute
any general waiver or amendment of the provisions of </font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">Elan License
Agreement, the JDOA or otherwise, a</font><font size="2" style="font-size:10.0pt;">nd no such waiver or release shall be deemed to be a
waiver or release of any future breach or failure to perform of any other right
under arising under this </font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">Elan License Agreement, the JDOA or otherwise.</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:0pt;">4</font><font size="1" style="font-size:3.0pt;letter-spacing:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;letter-spacing:0pt;">Intellectual Property.</font></b></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-family:'Times New Roman';letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">As provided in Clause
3.1.2 of the Elan License Agreement, Elan shall own all the Elan Improvements
(as defined in the Elan License Agreement) relating to the GR Know-How, and the
</font><font size="2" style="font-size:10.0pt;">EGTS Patents and the
EGTS Know-How </font><font size="2" style="font-size:10.0pt;letter-spacing:0pt;">(each as defined in the Elan License Agreement)</font><font size="2" style="font-size:10.0pt;">.</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">THE SYMBOL [***] IS USED TO INDICATE THAT A
PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPERATELY WITH THE
COMMISSION.&#160; CONFIDENTIAL TREATMENT HAS
BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION.</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>


<div align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:-.15pt;">
<!-- ZEQ.=1,SEQ=2,EFW="2106609",CP="DEPOMED, INC.",DN="5",CHK=641171,FOLIO='2',FILE="DISK008:[03PAL8.03PAL1238.EDGAR]EX10-13_1238.CHC",USER="DROCCON",CD='Mar 28 16:24 2003' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONFIDENTIAL TREATMENT REQUESTED</font></b></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Elan Improvements described in this Clause 4.1
include, but are not limited to, the data, know-how, materials and other
information listed in Schedule 1 hereto.</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">THE SYMBOL [***] IS USED TO INDICATE THAT A
PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPERATELY WITH THE
COMMISSION.&#160; CONFIDENTIAL TREATMENT HAS
BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION.</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>


<div align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:-.15pt;">
<!-- ZEQ.=1,SEQ=3,EFW="2106609",CP="DEPOMED, INC.",DN="5",CHK=702429,FOLIO='3',FILE="DISK008:[03PAL8.03PAL1238.EDGAR]EX10-13_1238.CHC",USER="DROCCON",CD='Mar 28 16:24 2003' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONFIDENTIAL TREATMENT REQUESTED</font></b></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:'Times New Roman';width:100.0%;">
 <tr style="font-family:'Times New Roman Bold';">
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <h3 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h3>
  </td>
  <td width="51%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:51.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ELAN CORPORATION, PLC</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <h3 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h3>
  </td>
 </tr>
 <tr style="font-family:'Times New Roman Bold';">
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <h3 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h3>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <h3 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h3>
  </td>
  <td width="33%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:33.26%;">
  <h3 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h3>
  </td>
  <td width="10%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:10.04%;">
  <h3 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h3>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <h3 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h3>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="6%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:6.22%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:1.98%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="33%" valign="top" style="padding:0in .7pt 0in .7pt;width:33.26%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="18%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:18.92%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="6%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:6.22%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:1.98%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="33%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:33.26%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/&#160; LIAM DANIEL</font></p>
  </td>
  <td width="18%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:18.92%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="33%" valign="top" style="padding:0in .7pt 0in .7pt;width:33.26%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:&#160; Liam Daniel</font></p>
  </td>
  <td width="10%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:10.04%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="33%" valign="top" style="padding:0in .7pt 0in .7pt;width:33.26%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:&#160; Company Secretary</font></p>
  </td>
  <td width="10%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:10.04%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="33%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:33.26%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="10%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:10.04%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="33%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:33.26%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="10%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:10.04%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <h4 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="60%" colspan="7" valign="top" style="padding:0in .7pt 0in .7pt;width:60.38%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ELAN PHARMA INTERNATIONAL
  LIMITED</font></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="34%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.94%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="2%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.26%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="33%" valign="top" style="padding:0in .7pt 0in .7pt;width:33.26%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="18%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:18.92%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.94%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="2%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:2.26%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="33%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:33.26%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/&#160; LIAM DANIEL</font></p>
  </td>
  <td width="18%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:18.92%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:&#160; Liam Daniel</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:&#160; Company Secretary</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <h4 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="60%" colspan="7" valign="top" style="padding:0in .7pt 0in .7pt;width:60.38%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DEPOMED DEVELOPMENT LTD.</font></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="34%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <h4 align="left" style="color:black;font-size:12.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.94%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="2%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.26%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="3" valign="bottom" style="padding:0in .7pt 0in .7pt;width:43.3%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.94%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="2%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:2.26%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:43.3%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/&#160; STEPHEN J. ROSSITER</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <h4 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:&#160; Stephen J. Rossiter</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <h4 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <h4 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:&#160; Director</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="51%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:51.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DEPOMED, INC.</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.94%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="2%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.26%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:43.3%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.94%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="2%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:2.26%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:43.3%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/&#160; JOHN N. SHELL</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <h4 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <h4 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="34%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;text-transform:uppercase;">Name</font><font size="2" style="font-size:10.0pt;">:&#160; John N. Shell</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <h4 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <h4 align="left" style="color:black;font-size:1.0pt;font-variant:small-caps;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;">&nbsp;</h4>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:&#160; Vice President, Operations</font></p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in .7pt 0in .7pt;width:39.62%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:8.2%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="34%" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:34.36%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.94%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="8%" valign="top" style="padding:0in .7pt 0in .7pt;width:8.88%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr height="0">
  <td width="229" style="border:none;"></td>
  <td width="34" style="border:none;"></td>
  <td width="2" style="border:none;"></td>
  <td width="11" style="border:none;"></td>
  <td width="192" style="border:none;"></td>
  <td width="6" style="border:none;"></td>
  <td width="52" style="border:none;"></td>
  <td width="51" style="border:none;"></td>
 </tr>
</table>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt 1.0in;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">THE SYMBOL [***] IS USED TO INDICATE THAT A
PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPERATELY WITH THE
COMMISSION.&#160; CONFIDENTIAL TREATMENT HAS
BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION.</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>


<div align="left" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;letter-spacing:-.15pt;">
<!-- ZEQ.=1,SEQ=4,EFW="2106609",CP="DEPOMED, INC.",DN="5",CHK=392003,FOLIO='4',FILE="DISK008:[03PAL8.03PAL1238.EDGAR]EX10-13_1238.CHC",USER="DROCCON",CD='Mar 28 16:24 2003' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="letter-spacing:-.15pt;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONFIDENTIAL TREATMENT REQUESTED</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SCHEDULE 1</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ELAN IMPROVEMENTS</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:'Times New Roman';width:100.0%;">
 <tr>
  <td width="2%" valign="top" style="padding:0in .7pt 0in .7pt;width:2.34%;">
  <p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:1.1%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="96%" valign="top" style="padding:0in .7pt 0in .7pt;width:96.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gastro-retentive
  formulation of [***] including any data, studies, clinical results, methods
  of manufacturing and methods of use related thereto.</font></p>
  </td>
 </tr>
 <tr>
  <td width="2%" valign="top" style="padding:0in .7pt 0in .7pt;width:2.34%;">
  <p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:1.1%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="96%" valign="top" style="padding:0in .7pt 0in .7pt;width:96.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gastro-retentive
  formulation of [***] including any data, studies, clinical results, methods
  of manufacturing and methods of use related thereto.</font></p>
  </td>
 </tr>
 <tr>
  <td width="2%" valign="top" style="padding:0in .7pt 0in .7pt;width:2.34%;">
  <p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:1.1%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="96%" valign="top" style="padding:0in .7pt 0in .7pt;width:96.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All information related to
  placebo studies related to the EGTS Technology and/or GR Technology (as each
  is defined in the Elan License Agreement).</font></p>
  </td>
 </tr>
 <tr>
  <td width="2%" valign="top" style="padding:0in .7pt 0in .7pt;width:2.34%;">
  <p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:1.1%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="96%" valign="top" style="padding:0in .7pt 0in .7pt;width:96.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All information generated
  within the JV on [***] including scale-up information and stability data.</font></p>
  </td>
 </tr>
 <tr>
  <td width="2%" valign="top" style="padding:0in .7pt 0in .7pt;width:2.34%;">
  <p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:1.1%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="96%" valign="top" style="padding:0in .7pt 0in .7pt;width:96.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All developments made
  related to the manufacturing apparatus for products made using the EGTS
  Technology and/or GR Technology.</font></p>
  </td>
 </tr>
 <tr>
  <td width="2%" valign="top" style="padding:0in .7pt 0in .7pt;width:2.34%;">
  <p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:1.1%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="96%" valign="top" style="padding:0in .7pt 0in .7pt;width:96.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All commercial information
  and contacts generated within the JV related to the EGTS Technology and/or GR
  Technology or the above-noted formulations.</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">THE SYMBOL [***] IS USED TO INDICATE THAT A
PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPERATELY WITH THE
COMMISSION.&#160; CONFIDENTIAL TREATMENT HAS
BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="3" style="font-size:12.0pt;">
<!-- ZEQ.=1,SEQ=5,EFW="2106609",CP="DEPOMED, INC.",DN="5",CHK=76672,FOLIO='5',FILE="DISK008:[03PAL8.03PAL1238.EDGAR]EX10-13_1238.CHC",USER="DROCCON",CD='Mar 28 16:24 2003' -->
<br clear="all" style="page-break-before:always;">
</font>

</div>

<BR>
<!-- SEQ=,FILE='QUICKLINK',USER=DROCCON,SEQ=,EFW="2106609",CP="DEPOMED, INC.",DN="5" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
